Loading stock data…
BON
$1.30+0.02 (+1.79%)
Market ClosedLast close May 1
Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Bon Natural Life Limited in the Basic Materials sector is trading at $1.30. The stock is currently near its 52-week low of $1.13, remaining 20.2% below its 200-day moving average. Technical signals show neutral RSI of 52 and bullish MACD crossover, explaining why BON maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 52) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.30
Potential Upside
5%
Whystock Fair Value$1.37
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and th...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$13.41M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-0.25
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
0.69%
Volume
Today's trading volume
4,045
Recent News
Treasury and Bond ETFs Are Back in Fashion: Here’s What to Own in April 2026
Volatility spiked in late March when the VIX reached 31.05 on March 27, 2026, before easing back to roughly 19.50, a level near the upper end of its typical range. The Federal Reserve has held its target rate at 3.50–3.75% since December 2025, and the 10‑year Treasury yield recently traded around 4.3%, within a 52‑week ... Treasury and Bond ETFs Are Back in Fashion: Here’s What to Own in April 2026
Be Wary Of Bon Natural Life (NASDAQ:BON) And Its Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Bon Natural Life announces distribution agreement with Merrill-Youli Trading
Bon Natural Life (BON) announced a non-exclusive sales distribution agreement with Tianjin Merrill-Youli Trading. The term of the agreement is 36 months with a total contract value of up to US$18 million. Pursuant to the agreement, Merrill-Youli will market, sell and distribute Bon’s Ambroxide and related natural fragrance compounds in the Asia-Pacific region. Merrill-Youli will primarily target the industrial fabric fragrance sector. Bon believes this partnership will help capitalize a leading